[PDF][PDF] Retrospective analysis of gefitinib and erlotinib in EGFR-mutated non-small-cell lung cancer patients
C Pui, C Gregory, Z Lunqing, LI Long… - Journal of Lung …, 2017 - lungdiseasesjournal.com
Objective: The objective of this study was to compare the efficacies of gefitinib and erlotinib
in treating EGFR-mutated non-small-cell lung cancer (NSCLC) patients. Methods: 319 EGFR …
in treating EGFR-mutated non-small-cell lung cancer (NSCLC) patients. Methods: 319 EGFR …
[HTML][HTML] Retrospective analysis of Gefitinib and Erlotinib in EGFR-mutated non-small-cell lung cancer patients
C Pui, C Gregory, Z Lunqing, LI Long… - Journal of Lung …, 2017 - lungdiseasesjournal.com
Objective: The objective of this study was to compare the efficacies of gefitinib and erlotinib
in treating EGFR-mutated non-small-cell lung cancer (NSCLC) patients. Methods: 319 EGFR …
in treating EGFR-mutated non-small-cell lung cancer (NSCLC) patients. Methods: 319 EGFR …
[PDF][PDF] Retrospective analysis of Gefitinib and Erlotinib in EGFR-mutated non-small-cell lung cancer patients
PI Chao, G Cheng, LQ Zhang, IL Lo… - Journal of Lung …, 2017 - pdfs.semanticscholar.org
Objective: The objective of this study was to compare the efficacies of gefitinib and erlotinib
in treating EGFR-mutated non-small-cell lung cancer (NSCLC) patients. Methods: 319 EGFR …
in treating EGFR-mutated non-small-cell lung cancer (NSCLC) patients. Methods: 319 EGFR …